Igm Biosciences earnings were -$198.9M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest IGMS earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$52.9M, up 44.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IGMS reported annual earnings of -$195.8M, with -20.5% growth.
What were Igm Biosciences's earnings last quarter?
On IGMS's earnings call on Invalid Date, Igm Biosciences (NASDAQ: IGMS) reported Q1 2025 earnings per share (EPS) of -$0.86, up 3.61% year over year. Total IGMS earnings for the quarter were -$52.89 million. In the same quarter last year, Igm Biosciences's earnings per share (EPS) was -$0.83.
As of the last Igm Biosciences earnings report, Igm Biosciences is currently losing money. Igm Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$198.87 million, a 16.06% decrease year over year.
What was IGMS's earnings growth in the past year?
As of Igm Biosciences's earnings date in Invalid Date, Igm Biosciences's earnings has grown year over year. IGMS earnings in the past year totalled -$198.87 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.